secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001493152-24-009247
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical upsizes revolver to $17M, extends maturity to 2029, removes EBITDA covenant
--------------------------------------------------------------------------------

- Revolving credit facility increased from $8M to $17M with MidCap Financial.
- Term loan amended to include an additional $10M tranche for acquisitions at MidCap's discretion.
- Maturity of both facilities extended to March 1, 2029.
- Minimum Adjusted EBITDA requirement removed; net product revenue covenants reset.
- Term loan interest margin reduced from 7.00% to 6.50%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315224009247/0001493152-24-009247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315224009247/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer